Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pritesh Shah currently holds 124,511 shares of NovoCure Ltd (NVCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pritesh Shah has been a net seller of NVCR stock. They have purchased $357.0K and sold $26.9M worth of shares.
Pritesh Shah's most recent insider trade was on Nov 7, 2023, when they sold 382 shares at $12.65 per share.
Pritesh Shah serves as Executive at NovoCure Ltd (NVCR). They have executed 127 insider transactions totaling $27.2M over their tenure at the company.
Pritesh Shah holds the position of Executive at NovoCure Ltd, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Pritesh Shah has shown a selling trading pattern, with $357.0K in total purchases and $26.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Pritesh Shah was on Jun 10, 2021, when they sold $5.1M worth of NVCR shares. This transaction involved 23,540 shares at $215.00 per share.
Pritesh Shah currently owns 124,511 shares of NovoCure Ltd (NVCR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pritesh Shah's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pritesh Shah has 127 Form 4 filings on record as an insider at NovoCure Ltd.
Set alerts for Pritesh Shah and 40,000+ other insiders.